salmeterol xinafoate has been researched along with Constriction, Pathological in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukkuda, T | 1 |
Aoshima, Y; Chida, K; Enomoto, N; Fujisawa, T; Hashizume, H; Inui, N; Nakamura, Y; Sato, J; Suda, T; Yokomura, K | 1 |
Langdon, RB; Legrand, C; Loeys, T; Pearlman, DS; Philip, G; Reiss, TF; VillarĂ¡n, C | 1 |
Chuchalin, AG; Gunawardena, KA; Helbling, A; Jasan, J; Langley, SJ; Laurenzi, M; Lee, TH; Leff, JA; Menten, J; O'Neill, SJ; Suskovic, S; van Noord, JA; Villaran, C | 1 |
1 review(s) available for salmeterol xinafoate and Constriction, Pathological
Article | Year |
---|---|
[Recent study on pathogenesis of bronchial asthma and the therapeutic strategy].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchi; Bronchial Diseases; Bronchial Hyperreactivity; Bronchitis; Constriction, Pathologic; Drug Therapy, Combination; Eosinophilia; Glucocorticoids; Humans; Salmeterol Xinafoate; Theophylline | 2004 |
2 trial(s) available for salmeterol xinafoate and Constriction, Pathological
Article | Year |
---|---|
Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction.
Topics: Acetates; Adolescent; Adult; Albuterol; Anti-Asthmatic Agents; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Administration Schedule; Exercise; Female; Forced Expiratory Volume; Humans; Male; Quinolines; Salmeterol Xinafoate; Sulfides | 2007 |
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group.
Topics: Acetates; Adolescent; Adult; Albuterol; Asthma, Exercise-Induced; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Cyclopropanes; Double-Blind Method; Female; Humans; Male; Middle Aged; Quinolines; Salmeterol Xinafoate; Single-Blind Method; Sulfides | 1999 |
1 other study(ies) available for salmeterol xinafoate and Constriction, Pathological
Article | Year |
---|---|
Management of interleukin-2-induced severe bronchoconstriction.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Inflammatory Agents; Antineoplastic Agents; Bronchial Diseases; Bronchodilator Agents; Constriction, Pathologic; Delayed-Action Preparations; Drug Administration Schedule; Female; Fluticasone; Forced Expiratory Volume; Hemangioendothelioma; Humans; Infusions, Intravenous; Injections, Intralesional; Interleukin-2; Male; Middle Aged; Premedication; Salmeterol Xinafoate; Skin Neoplasms | 2007 |